Get the Stockscreener App
1.72
6.83%
0.11
After Hours:
1.72
Caribou Biosciences Inc stock is traded at $1.72, with a volume of 853.02K.
It is up +6.83% in the last 24 hours and down -9.47% over the past month.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
See More
Previous Close:
$1.61
Open:
$1.62
24h Volume:
853.02K
Relative Volume:
0.39
Market Cap:
$160.77M
Revenue:
$34.48M
Net Income/Loss:
$-102.07M
P/E Ratio:
-1.1781
EPS:
-1.46
Net Cash Flow:
$-104.90M
1W Performance:
+8.18%
1M Performance:
-9.47%
6M Performance:
+25.55%
1Y Performance:
-8.51%
1-Day Range:
$1.61
$1.72
1-Week Range:
$1.54
$1.72
52-Week Range:
$0.66
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
Name
Caribou Biosciences Inc
Sector
Industry
Phone
510-982-6030
Address
2929 7TH STREET, SUITE 105, BERKELEY
Compare CRBU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.72 | 150.48M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-08-23 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-31-23 | Initiated | Evercore ISI | Outperform |
| Jul-11-23 | Initiated | Truist | Buy |
| Feb-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Dec-01-21 | Initiated | Oppenheimer | Outperform |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Nov-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Aug-17-21 | Initiated | BofA Securities | Buy |
| Aug-17-21 | Initiated | Citigroup | Neutral |
| Aug-17-21 | Initiated | SVB Leerink | Outperform |
View All
Caribou Biosciences Inc Stock (CRBU) Latest News
Can Caribou Biosciences Inc. stock continue upward trend2026 world cup usa national team qualification midfield engines possession football winner prediction tactical review - Улправда
What is the fair value of Caribou Biosciences Inc. stock now2026 world cup usa national team round of 32 key players pressing system tactical prediction expert opinion - Улправда
Aug Intraday: Can Caribou Biosciences Inc stock sustain revenue growthMarket Weekly Review & Daily Volume Surge Trade Alerts - moha.gov.vn
Will Caribou Biosciences Inc stock remain a Wall Street favoriteGold Moves & Low Risk Entry Point Guides - moha.gov.vn
How sustainable is Caribou Biosciences Inc. stock dividend payoutIPO Market Watch & Get The Analyst Consensus With One Click - bollywoodhelpline.com
What valuation multiples suggest for Caribou Biosciences Inc. stockGap Fill Strategies & Affordable Growth Investments - bollywoodhelpline.com
Caribou Biosciences (NASDAQ:CRBU) Trading Up 2.4%Should You Buy? - MarketBeat
Why Caribou Biosciences Inc. stock is popular among millennialsJuly 2025 News Drivers & Weekly Momentum Picks - Улправда
Will Caribou Biosciences Inc. stock benefit from automationWeekly Market Outlook & Low Risk High Reward Trade Ideas - Bölüm Sonu Canavarı
How analysts rate Caribou Biosciences Inc. stock today2025 Short Interest & Accurate Entry and Exit Point Alerts - DonanımHaber
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Published on: 2025-12-19 16:09:33 - Улправда
Can Caribou Biosciences Inc. stock sustain institutional interestJuly 2025 Setups & Smart Swing Trading Alerts - DonanımHaber
How risky is Caribou Biosciences Inc. stock nowQuarterly Market Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Wall Street Recap: Why hedge funds are buying Caribou Biosciences Inc. stock2025 Historical Comparison & Consistent Profit Trading Strategies - Улправда
Targets Report: How sustainable is Caribou Biosciences Inc. stock dividend payoutWeekly Trade Report & Real-Time Volume Trigger Notifications - Улправда
Will Caribou Biosciences Inc. stock remain a Wall Street favoriteM&A Rumor & Reliable Entry Point Alerts - Улправда
Published on: 2025-12-19 08:19:09 - Улправда
Published on: 2025-12-19 00:46:22 - Улправда
What analyst consensus says on Caribou Biosciences Inc. stockJuly 2025 Action & High Accuracy Buy Signal Tips - Улправда
Market Overview: Why Caribou Biosciences Inc. stock is a value investor pickJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - Улправда
Chart Watch: How risky is Caribou Biosciences Inc stock nowWeekly Trade Review & AI Enhanced Trading Alerts - moha.gov.vn
Caribou Biosciences Earnings Notes - Trefis
Published on: 2025-12-14 05:29:10 - earlytimes.in
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Will Caribou Biosciences Inc. stock reach Wall Street targets2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Caribou Biosciences Target of Unusually Large Options Trading (NASDAQ:CRBU) - MarketBeat
Caribou Biosciences to Host Expert Panel on Access Expansion for vispa-cel CAR-T Therapy at ASH Annual Meeting - Quiver Quantitative
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 - 富途牛牛
MACD Signal: Will ABEV stock outperform value stocksJuly 2025 Earnings & Accurate Intraday Trading Signals - BỘ NỘI VỤ
Earnings Risk: What analyst consensus says on Caribou Biosciences Inc stockJuly 2025 Pullbacks & Free Daily Entry Point Trade Alerts - BỘ NỘI VỤ
Caribou Biosciences CEO to address Evercore Healthcare Conference - Traders Union
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Caribou Biosciences, Inc. $CRBU Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Caribou Biosciences signals access challenge in CAR-T cell therapy - Traders Union
Analyzing Caribou Biosciences Inc. with multi timeframe chartsJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
Is Caribou Biosciences Inc. stock positioned well for digital economyJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Is it time to cut losses on Caribou Biosciences Inc.Rate Hike & Verified Momentum Stock Watchlist - newser.com
What is HC Wainwright's Estimate for CRBU FY2025 Earnings? - MarketBeat
Can Caribou Biosciences Inc. stock maintain operating margins - newser.com
Is Caribou Biosciences Inc. stock a contrarian buyEarnings Recap Summary & AI Driven Stock Price Forecasts - newser.com
Caribou Biosciences Inc Stock (CRBU) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):